Michael Thomas Henderson, Chief Executive Officer at Apogee Therapeutics, sold APGE on Jun 22, 2026
Prices as of Sep 4 · price update delayed · Every feed →
▼ SELL$10.6M80,000 shares at $132.54Michael Thomas Henderson Chief Executive OfficerAPGE Apogee Therapeutics, Inc.
- Traded
- Jun 22, 2026
- Disclosed
- Jun 24, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
APGE since disclosure
+1.8%
after the sale
Similar stocks (XLV) since disclosure
+11.8%
XLV — its sector index fund
Change in closing price from Jun 24, 2026 (the first trading day on or after disclosure) to Sep 4, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.